Lattice Biologics Company Description
Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide.
It develops acellular demineralized bone scaffold, a human cortical bone demineralized that are used in various applications in orthopedic, neurological, trauma, oral/maxillofacial, and reconstructive procedures; and acellular dermal matrix that provides a natural collagen tissue scaffold that promotes cellular ingrowth, tissue vascularization, and regeneration The company also develops amniotic fluid-based products, such as AmnioBoost and AmnioBlast.
In addition, it sells traditional allografts for multi-disciplinary applications, including orthopedics, neurology, podiatry, and oral/maxillofacial.
The company is headquartered in Belgrade, Montana.
Contact Details
Address: 512 East Madison Avenue Belgrade, Montana 59714 United States |
Stock Details
| Ticker Symbol | LBLTF |
| Exchange | OTCMKTS |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| ISIN Number | CA5184101056 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Donna Medina | Interim Chief Financial Officer |